Home Pharmacy
More than half of patients initiating statin therapy have a suboptimal low-density lipoprotein cholesterol response within 24 months

Over Half of Patients Have Suboptimal Response to Statins

Suboptimal responders have increased risk for incident cardiovascular disease
Older adults (aged ≥75 years) undergoing antihypertensive treatment with systolic blood pressure (SBP) >150 mm Hg have less cognitive decline than those with SBP <130 mm Hg

Intensive BP Lowering May Up Cognitive Decline in Elderly

For those on antihypertensive treatment, cognitive decline greater with SBP <130 versus >150 mm Hg
Antiepileptic drug use may increase the risk for pneumonia in patients with Alzheimer disease

AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients

Risk for pneumonia highest within first month of antiepileptic drug use but persists through two years
In pregnant women with polycystic ovary syndrome

Metformin May Cut Risk for Prematurity, Miscarriage in PCOS

But no significant differences seen in gestational DM risk between metformin users, nonusers
Standardizing demographic data can improve the accuracy of patient matching

Standardizing Demographics Ups Accuracy of Patient Matching

Standardization of address and last name improved sensitivity from 81.3 to 91.6 percent
Canagliflozin is associated with a reduced risk for renal and cardiovascular events for patients with type 2 diabetes and kidney disease

Canagliflozin Seems Effective for Patients With T2DM, Kidney Disease

Reductions seen in risk for kidney failure, cardiovascular disease with canagliflozin versus placebo
The ongoing Ebola outbreak in Congo is of "deep concern" but does not yet qualify as a global emergency

WHO: Congo Ebola Outbreak Still Not a Global Emergency

Outbreak, which began on Aug. 1, 2018, is second deadliest in history
Medication shortages are frequently reported by pharmacy practice managers

Pharmacy Practice Managers Report Frequent Drug Shortages

More than one-third of respondents reported no administrative methods for responding to shortages
Two position statements developed in relation to drug pricing and step therapy have been issued by the American College of Rheumatology.

ACR Issues Position Statements on Drug Pricing, Step Therapy

Statements emphasize need for safe, convenient, affordable access to rheumatology treatments
The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor genetic alterations was granted accelerated approval by the U.S. Food and Drug Administration

FDA Approves Personalized Tx for Metastatic Bladder Cancer

Balversa indicated for treatment of bladder cancer with FGFR3 or FGFR2 genetic alteration